This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Clinicalresearch involves trial and error as part of the drug development process. Learn more about how to optimise drugtrials and the important role of participants in clinicalresearch.
Amid a period of clinical holds and legal tangles, the US antibody specialist CytoDyn has reached a settlement to resolve legal disputes with its former contract research organization (CRO) Amarex ClinicalResearch.
Pfizer and partner Valneva are scrapping data from roughly half of the participants in a Phase 3 trial of a Lyme disease vaccine candidate after uncovering quality issues with a third-party clinicaltrial operator.
Clinicaltrials are studies involving human volunteers to research ways to prevent, detect, and treat various medical conditions. The goal is to identify safer, more effective methods of treating illnesses using new drugs or new combinations of existing drugs.
Sites need to be close enough for travel, and the number of site visits and trial appointments must also be manageable for people living with the complications of having little-known and rarely-researched orphan diseases. In fact, how do rare disease patients even feel about clinicaltrials?
Just as clinicalresearchers in other therapeutic areas have renewed their commitment to improving participant diversity in clinicaltrials, so too have those working in Alzheimer’s research. Fortunately, there are a number of researchers working on this issue.
The solution enables pharmaceutical sponsors and CROs to evaluate, qualify and routinely monitor research sites for studies without physical travel. COVID-19 spurred a significant increase in Virtual Pre-Site inquiries to accommodate site monitoring for existing studies and to expedite study startups for COVID and other drugtrials.
A recent survey of clinicaltrial professionals found that more than two-thirds of respondents (61%) believe giving patients choice will have a positive impact on clinicalresearch, and well over half (58%) said that their organisations plan to give patients the option to choose how they participate in clinicaltrials moving forward.
At the beginning of September, Velocity ClinicalResearch topped Business North Carolina ’s 2024 Fast 40 list. For a clinicaltrials organization to achieve this level of scale is notable. This is vital if we’re to ensure that drugtrials are inclusive and deliver results that are representative of the entire population.
And a fragmented clinicaltrials industry has made it a prime target for private equity, which often consolidates markets by merging companies. To date, 11 of the 25 private equity firms identified by industry tracker PitchBook as the top investors in health care have bought stakes in clinicalresearch companies.
Unlike commercial pharmaceutical packaging, the primary consideration in clinicaltrial packaging is protecting the product quality and reliability for research. Furthermore, the list includes clinical supply packaging, as well as labelling, storage, and logistics service providers for drugtrial projects.
Analysing real-world health data could help overcome the bias towards men in traditional medical research, says Sensyne Health’s Dr Lucy Mackillop. Medical research has often focused on men, meaning that the insights gained have not always been reflective of how women would react to a treatment or disease.
BioPharma Dive interviewed our Derek Ansel on how to conduct psychedelic clinicalresearch. In April 2022, the Food and Drug Administration (FDA) issued draft guidance on developing a “Race and Ethnicity Diversity Plan” for clinicaltrials. Looking to diversify the reach of your orphan drugtrial?
The process of drug development typically starts with the identification of a potential target for a drug. Once the target is identified, researchers work to develop a compound that can interact with it. AI-based analysis can provide insight into participant behavior that informs how researchers design trials.
In all, 80% of the nearly 37,600 PIs who were active in drug studies for some period within the 2018, 2019, and 2020 timeframe ran just one to five trials with industry funding in that three-year block. and lead author of the article due to appear in the December 2022 issue of ClinicalResearcher.
Diverse clinicaltrials are a matter of equity and essential for the validity and reliability of research outcomes. Historically, racial and ethnically minoritized groups or populations have been excluded from clinicaltrials, leading to a lack of data on how different demographic subgroups respond to treatments.
This started back in 1993 when the FDA established guidelines to increase diversity by gender and race/ethnicity of participants in clinicaltrials that were contributing to new drug approvals. Why Should We Care About Diversity and Equity in ClinicalResearch? In the same webinar, Dr. Hansie M.
Transforming the environment of clinicaltrials from conventional to decentralized, however, requires certain guidelines and strategies that may vary with the disease area, type of drug, trial activities, and others. The post Reimagining ClinicalTrials: Why are Virtual ClinicalTrials Becoming the New Normal?
Although a few are out there, phosphorylated tau (P-tau) may enable even earlier and more accurate detection, according to Eli Lilly-associated researchers speaking at the ClinicalTrials on Alzheimer’s Disease (CTAD) virtual conference in early November. Jeff Dage, Ph.D., But, as Iwatsubo cautioned, “We are at the early stages.
pic.twitter.com/dqmWPpxPdE — Adam Feuerstein (@adamfeuerstein) July 14, 2015 In another tweet, he suggests that the act will "decimate" informed consent in drugtrials. Section 505(i) - the section this act proposes to amend - instructs the Secretary of Health and Human Services to propagate rules regarding clinicalresearch.
” Conducting this kind of research in Finland makes sense, as it has a sophisticated healthcare system but a small population, which can make it challenging to carry out clinicalresearch using traditional approaches. . “On the other hand, [they] should be able to tell a user if they are no longer reliable.”
Medical device trials, however, are typically smaller in scale and require fewer phases [than drugtrials]. The information from this site goes on to describe how medical device studies are divided into three different classes, rather than into the familiar phases of drug studies. Other Medical Devices.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content